| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
92,820,000 |
| Market
Cap: |
33.45(M) |
| Last
Volume: |
2,227,430 |
Avg
Vol: |
2,221,214 |
| 52
Week Range: |
$0.3604 - $0.3604 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teligent is a generic pharmaceutical company. Under its own label, Co. markets and sells generic topical, branded generic and generic injectable, and generic ophthalmic pharmaceutical products in the United States and Canada. Co. also provides contract manufacturing services to the pharmaceutical, over-the-counter (OTC), and cosmetic markets. Co. develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as the OTC and cosmetic markets. These products are used in a range of applications from cosmetics and cosmeceuticals to the prescription treatment of conditions like dermatitis, psoriasis and eczema.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pate R Carter |
Director |
– • – |
2021-05-27 |
4 |
B |
$0.55 |
$16,491 |
D/D |
30,000 |
30,000 |
2.39 |
- |
|
| Weir Donald V |
10% Owner |
– – • |
2020-08-26 |
4 |
S |
$1.24 |
$697,494 |
D/D |
(560,618) |
17,515 |
|
- |
|
| Weir Donald V |
10% Owner |
– – • |
2020-08-25 |
4 |
S |
$1.13 |
$113,254 |
D/D |
(100,000) |
102,621 |
|
- |
|
| Weir Donald V |
10% Owner |
– – • |
2020-08-21 |
4 |
S |
$1.66 |
$201,611 |
D/D |
(121,394) |
117,805 |
|
- |
|
| Weir Donald V |
10% Owner |
– – • |
2020-08-19 |
4 |
S |
$2.25 |
$196,787 |
D/D |
(87,271) |
136,237 |
|
- |
|
| Chaudhuri Bhaskar |
Director |
– • – |
2019-06-03 |
4 |
B |
$0.70 |
$7,005 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Sabatino Thomas J Jr |
Director |
– • – |
2019-05-31 |
4 |
B |
$0.66 |
$16,520 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| Celentano John E |
Director |
– • – |
2019-05-31 |
4 |
B |
$0.65 |
$12,904 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| Gale James C |
Director |
– • – |
2019-05-31 |
4 |
B |
$0.66 |
$13,166 |
D/D |
20,000 |
394,624 |
2.39 |
- |
|
| Ben-Maimon Carole |
Director |
– • – |
2019-05-30 |
4 |
B |
$0.59 |
$5,885 |
D/D |
10,000 |
16,000 |
2.39 |
- |
|
| Grenfell-Gardner Jason |
President & CEO |
• • – |
2019-05-23 |
4 |
B |
$0.69 |
$17,335 |
D/D |
25,000 |
119,849 |
2.81 |
- |
|
| Gale James C |
Director |
– • – |
2019-05-23 |
4 |
B |
$0.69 |
$13,814 |
D/D |
20,000 |
374,624 |
2.39 |
- |
|
| Richardson Stephen |
Chief Scientific Officer |
• – – |
2018-12-14 |
4 |
B |
$1.78 |
$21,372 |
D/D |
12,000 |
51,209 |
2.74 |
- |
|
| Finio Damian |
CFO |
• – – |
2018-12-14 |
4 |
B |
$1.82 |
$18,200 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| Richardson Stephen |
Chief Scientific Officer |
• – – |
2018-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,333 |
23,077 |
|
- |
|
| Grenfell-Gardner Jason |
President & CEO |
• • – |
2018-09-04 |
4 |
AS |
$4.00 |
$211,201 |
D/D |
(52,800) |
94,849 |
|
- |
|
| Wilson Martin |
General Counsel |
• – – |
2018-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
|
- |
|
| Grenfell-Gardner Jason |
President & CEO |
• • – |
2017-12-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
39,975 |
147,649 |
|
- |
|
| Ben-Maimon Carole |
Director |
– • – |
2017-11-13 |
4 |
B |
$3.48 |
$17,409 |
D/D |
5,000 |
6,000 |
2.39 |
- |
|
| Gale James C |
Director |
– • – |
2017-11-10 |
4 |
B |
$3.81 |
$57,137 |
D/D |
15,000 |
354,624 |
2.39 |
- |
|
| Koehler Steven H |
Director |
– • – |
2017-11-10 |
4 |
B |
$3.61 |
$18,088 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Richardson Stephen |
Chief Scientific Officer |
• – – |
2017-11-09 |
4 |
B |
$3.13 |
$20,056 |
D/D |
6,410 |
14,744 |
2.74 |
- |
|
| Collins Jenniffer |
CFO |
• – – |
2017-11-08 |
4 |
B |
$3.04 |
$21,280 |
D/D |
7,000 |
19,206 |
2.74 |
- |
|
| Ben-Maimon Carole |
Director |
– • – |
2016-03-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| Gale James C |
Director |
– • • |
2016-03-11 |
4 |
B |
$4.91 |
$73,718 |
I/I |
15,000 |
25,000 |
2.25 |
- |
|
37 Records found
|
|
Page 1 of 2 |
|
|
